Investigational Drug Information for Silicon dioxide
✉ Email this page to a colleague
What is the development status for investigational drug Silicon dioxide?
Silicon dioxide is an investigational drug.
There have been 7 clinical trials for Silicon dioxide.
The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2011.
The most common disease conditions in clinical trials are Renal Insufficiency, Celiac Disease, and Hypersensitivity. The leading clinical trial sponsors are German Federal Ministry of Education and Research, Florian Michel, and Autism Speaks.
Summary for Silicon dioxide
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 317 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2011-03-01) |
| Vendors | 56 |
Recent Clinical Trials for Silicon dioxide
| Title | Sponsor | Phase |
|---|---|---|
| Celiac Disease and Vitamin Status: Evaluation of the Effect of Supplementation With a Probiotic (VIVOMIXX®) in a Cohoort of Celiac Patients | University of Milan | Phase 4 |
| Probiotics for Quality of Life in Autism Spectrum Disorders | Autism Speaks | Early Phase 1 |
| Probiotics for Quality of Life in Autism Spectrum Disorders | Autism Treatment Network | Early Phase 1 |
Clinical Trial Summary for Silicon dioxide
Top disease conditions for Silicon dioxide
Top clinical trial sponsors for Silicon dioxide
US Patents for Silicon dioxide
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
